Clinical Trial Update: Intranasal Glucagon and Energy Balance [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for intranasal glucagon assessing energy balance in obesity across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• intranasal glucagon (glucagon)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Obesity | Phase 2, Phase 3 | Status: UNKNOWN